Dandan Xu

Down-regulation of interleukin-2 predicts poor prognosis and associated with immune escape in lung adenocarcinoma

Yongwang Hou, Zhicong Yang, Baoli Xiang, 2023, International journal of immunopathology and pharmacology.

Investigating gene signatures associated with immunity in colon adenocarcinoma to predict the immunotherapy effectiveness using NFM and WGCNA algorithms

Weizheng Liang, Xiushen Li, Dandan Xu, 2024, Aging.

Metformin is a potential therapeutic for COVID-19/LUAD by regulating glucose metabolism

Yongwang Hou, Zhicong Yang, Baoli Xiang, 2024, Scientific reports.

Activating transcription factor 3 is a new biomarker correlation with renal clear cell carcinoma progression

Yongwang Hou, Zhicong Yang, Dandan Xu, 2024, International journal of immunopathology and pharmacology.

The burgeoning spatial multi-omics in human gastrointestinal cancers

Dandan Xu, Jun Xue, Peng Wang, 2024, PeerJ.

Down-regulation of EZH2 genes targeting RUNX3 affects proliferation, invasion, and metastasis of human colon cancer cells by Wnt/β-catenin signaling pathway

Lei Han, Xueliang Wu, J. Xue, 2023, Aging.